{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-048570","form_type":"8-K","ticker":"RFL","cik":"0001713863","company_name":"Rafael Holdings, Inc.","filed_at":"2023-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.179287+00:00","generated_at":"2026-06-14T02:10:06.488931+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Rafael Holdings reports Q3 net loss of $1.5M; invests $2.1M in Cyclo Therapeutics","bullets":["Net loss from continuing operations $1.5M ($0.06/sh) vs $5.0M ($0.25/sh) year ago.","Cash, equivalents and marketable securities $82.4M as of April 30, 2023.","Made initial $2.1M investment in Cyclo Therapeutics and agreement to invest additional $5M.","R&D expenses fell to $0.7M from $1.4M on winding down early-stage programs.","General and administrative expenses $2.3M for Q3, including $0.6M stock-based comp."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-048570","json":"https://secwatch.observer/filing/0001213900-23-048570.json","markdown":"https://secwatch.observer/filing/0001213900-23-048570.md","text":"https://secwatch.observer/filing/0001213900-23-048570.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1713863/000121390023048570/0001213900-23-048570-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1713863/000121390023048570/ea180272-8k_rafaelhold.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T02:10:06.488931+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9d9197b9ac53b844d11ef4ebb6cbb97b07fed554","claim":"Rafael Holdings, Inc. reported the third quarter of fiscal 2023 for the three months ended April 30, 2023 results: net income net loss from continuing operations of $1.5 million, or $0.06 per share, EPS $0.06 per share.","evidence_excerpt":"Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1713863/000121390023048570/0001213900-23-048570-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter of fiscal 2023 for the three months ended April 30, 2023"},{"label":"Net income","value":"net loss from continuing operations of $1.5 million, or $0.06 per share"},{"label":"EPS","value":"$0.06 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}